Xue Meng

7PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 06, 2026
Real-world analysis of perioperative strategies for driver gene-positive resectable non-small cell lung cancer.

|Jun 19, 2026
Neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA-IIIB non-small cell lung cancer: integrated multidimensional biomarker analysis from a phase II study.

|Mar 18, 2026
Low-Dose Intestinal Irradiation Enhances the Efficacy and Prognosis of PD-1 Blockade in Metastatic Non-Small Cell Lung Cancer.

Baiyang Huang, Jiarui Zhao, Jingyu Zhu

|Sep 15, 2024
Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial.

Xiao Han, Jun Guo, Lingyu Li

|Apr 18, 2024
Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer.

Ying Fu, Qing Liu, Xiaohan Wang

|Feb 07, 2024
A retrospective analysis of optimal timing of thoracic radiotherapy for driver gene-negative metastatic non-small cell lung cancer.

Yanan Wang, Zhenhua Gao, Wen Zhao

Pageof 2

Frequent Collaborators

2 joint publications

Guoxin Cai

2 joint publications

Jinming Yu

1 joint publications

Jisheng Li

1 joint publications

Xiao Han